Atrioventricular septal defect surgery

Jump to navigation Jump to search

Atrioventricular septal defect Microchapters

Home

Patient Information

Overview

Classification

Pathophysiology

Causes

Differentiating Atrioventricular septal defect from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

MRI

CT

Echocardiography

Cardiac Catheterization

Treatment

Medical Therapy

Surgery

Prevention

Pregnancy

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Atrioventricular septal defect surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Atrioventricular septal defect surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Atrioventricular septal defect surgery

CDC on Atrioventricular septal defect surgery

Atrioventricular septal defect surgery in the news

Blogs on Atrioventricular septal defect surgery

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Atrioventricular septal defect surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Surgery

The image below shows repair of the atrioventricular cleft in a case of atrioventricular septal defect.


The image below shows repair of the mitral cleft in a case of atrioventricular septal defect.












2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[1]

Therapeutic Recommendations for Atrioventricular Septal Defect

Class I
1. Surgery for severe left atrioventricular valve regurgitation is recommended per GDMT indications for mitral regurgitation.(Level of Evidence: C-LD)
2.Surgery for primary repair of atrioventricular septal defect or closure of residual shunts in adults with repaired atrioventricular septal defect is recommended when there is a net left-to-right shunt (Qp:Qs ≥1.5:1), PA systolic pressure less than 50% systemic and pulmonary vascular resistance less than one third systemic.

(Level of Evidence: C-EO)

Class IIa
1.Operation for discrete LVOT obstruction in adults with atrioventricular septal defect is reasonable with a maximum gradient of 50 mm Hg or greater, a lesser gradient if HF symptoms are present, or if concomitant moderate-to-severe mitral or AR are present. (Level of Evidence: C-EO)
Class IIb
1.Surgery for primary repair of atrioventricular septal defect or closure of residual shunts in adults with repaired atrioventricular septal defect may be considered in the presence of a net left-to-right shunt (Qp:Qs ≥1.5:1), if PA systolic pressure is 50% or more systemic, and/or pulmonary vascular resistance is greater than one third systemic. (Level of Evidence: C-EO)

2008 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)[2]

Recommendations for Surgical Therapy (DO NOT EDIT)[2]

Class I
"1. Surgeons with training and expertise in CHD should perform operations for AVSD.(Level of Evidence: C)"
"2. Surgical reoperation is recommended in adults with previously repaired AVSD with the following indications:"
"a. Left AV valve repair or replacement for regurgitation or stenosis that causes symptoms, atrial or ventricular arrhythmias, a progressive increase in LV dimensions, or deterioration of LV function. (Level of Evidence: B)"
"b. LVOT obstruction with a mean gradient greater than 50 mm Hg or peak instantaneous gradient greater than 70 mm Hg, or a gradient less than 50 mm Hg in association with significant mitral regurgitation or AR. (Level of Evidence: B)"
"c. Residual/recurrent ASD or VSD with significant left-to-right shunting (refer to Section 2.0, Atrial Septal Defect, and Section 3.0, Ventricular Septal Defect). (Level of Evidence: B)"

References

  1. Stout KK, Daniels CJ, Aboulhosn JA, Bozkurt B, Broberg CS, Colman JM; et al. (2019). "2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". J Am Coll Cardiol. 73 (12): 1494–1563. doi:10.1016/j.jacc.2018.08.1028. PMID 30121240.
  2. 2.0 2.1 Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA; et al. (2008). "ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease). Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". J Am Coll Cardiol. 52 (23): e1–121. doi:10.1016/j.jacc.2008.10.001. PMID 19038677.

Template:WH Template:WS CME Category::Cardiology